• New study from University Hospitals, Case Western Reserve University, and the Cleveland VA identifies a potential new treatment strategy for Parkinson's disease.
  • Scientists found that blocking the enzyme 15-PGDH protected brain cells and improved outcomes in multiple preclinical models of Parkinson's disease.
  • The findings suggest that drugs already being developed for other uses could potentially also be used to treat Parkinson's disease and other neurodegenerative conditions.